Paul Harker‐Murray

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma

David T. Teachey, Meenakshi Devidas, Brent L. Wood et al. · Journal of Clinical Oncology · 2022 · 148 citations · Full text

Medicine, Oncology, Pharmacology +17

Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells

Keli L. Hippen, Paul Harker‐Murray, Stephen B. Porter et al. · Blood · 2008 · 141 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Bacterial meningitis from <i>Rothia mucilaginosa</i> in patients with malignancy or undergoing hematopoietic stem cell transplantation

Alisa B. Lee‐Sherick, Paul Harker‐Murray, Patricia Ferrieri et al. · Pediatric Blood & Cancer · 2007 · 41 citations

Life Sciences, Microbiology, Pediatrics +17

Allogeneic Hematopoietic Cell Transplantation in Children with Relapsed Acute Lymphoblastic Leukemia Isolated to the Central Nervous System

Paul Harker‐Murray, Avis J. Thomas, John E. Wagner et al. · Biology of Blood and Marrow Transplantation · 2008 · 28 citations · Full text

Medicine, Hematology, Pediatrics +15

Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults

Paul Harker‐Murray, Christine Mauz‐Körholz, Thierry Leblanc et al. · Blood · 2022 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +17